Some of my patients minimize the side effects of GLP-1 medication because they dont want to lower their dose or stop taking it, which can lead to serious complications
Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R
It has shown significant promise as an effective intervention against type 2 diabetes (T2D) and excessive body weight, resulting in the United States Food and Drug Administration (FDA) approving its use against both conditions in May 2022 for T2D and November 2023 for obesity
Consult a healthcare professional if on medications or managing health conditions
Here are some tried-and-true tips to help you maximize your results: Stick to your dose schedule
10.1016/j.celrep.2017.02.054 223 PudloM.DemougeotC.Girard-ThernierC